Daniel Estes

Daniel Estes

Director/Board Member at
Semnur, Inc.
45 year
Health Technology
Consumer Services
Finance

Profile

Daniel J.
Estes
is currently Director at Semnur, Inc., Cirius Therapeutics, Inc. (Independent Director since 2017), Lengo Therapeutics, Inc., Inipharm, Inc., Radionetics Oncology, Inc., and General Partner at Frazier Management LLC since 2020.
Former positions include Independent Director at Sierra Oncology, Inc. from 2017 to 2019, Independent Director at Arcutis Biotherapeutics, Inc. from 2017 to 2020, Director at Outpost Medicine, Inc., Director at Sudo Biosciences, Inc., Consultant at McKinsey & Co., Inc. in 2011, Research Assistant at Stanford University in 2003, and Researcher at the University of Michigan from 2004 to 2008.
Education includes an undergraduate degree from Stanford University conferred in 2003 and a doctorate from the University of Michigan conferred in 2008.

Daniel Estes active positions

CompaniesPositionStart
Private Equity Investor 01/04/2011
Director/Board Member -
Director/Board Member 01/03/2017
Director/Board Member -
Director/Board Member -
Director/Board Member -

Former positions of Daniel Estes

CompaniesPositionEnd
ARCUTIS BIOTHERAPEUTICS, INC. Director/Board Member 01/08/2020
SIERRA ONCOLOGY, INC. Director/Board Member 22/11/2019
Corporate Officer/Principal 31/03/2011
░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Daniel Estes's experience

Training of Daniel Estes

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

98

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Finance

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!